Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
Experimental Neurology|December 31, 2002
Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the ratMarie-Thérèse Armentero, Roberto Fancellu, Giuseppe Nappi, et al.
Parkinson'S Disease|July 4, 2012
A(2A) Receptor Antagonism and Dyskinesia in Parkinson's DiseaseMicaela Morelli, Fabio Blandini, Nicola Simola, et al.
Oxidative Medicine and Cellular Longevity|August 29, 2013
SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegenerationPamela Milani, Giulia Ambrosi, Omar Gammoh, et al.
Current Neurology and Neuroscience Reports|March 7, 2023
Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging ApproachElisa Menozzi, Anthony H V Schapira, Fabio Blandini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 2021
Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA MutationsSilvia Paola Caminiti, Giulia Carli, Micol Avenali, et al.
Neurobiology of Disease|October 7, 2006
Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's diseaseMarie-Thérèse Armentero, Giovanna Levandis, Giuseppe Nappi, et al.
Free Radical Biology & Medicine|October 14, 2015
Fibroblasts from skin biopsies as a tool for biomarker discovery in Parkinson׳s diseasePier Giorgio Mastroberardino, Giulia Ambrosi, Fabio Blandini, et al.
Neurobiology of Disease|November 18, 2005
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's diseaseMarie-Thérèse Armentero, Roberto Fancellu, Giuseppe Nappi, et al.
Neurobiology of Disease|October 16, 2007
Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's diseaseGiovanna Levandis, Eleonora Bazzini, Marie-Thérèse Armentero, et al.
Neuroimage. Clinical|May 15, 2022
Action and emotion perception in Parkinson's disease: A neuroimaging meta-analysisMaria Arioli, Zaira Cattaneo, Maria Luisa Rusconi, et al.
Pageof 12